EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
EQHA.U
EQHA.U was delisted on the 21st of December, 2022.
35 hedge funds and large institutions have $66.8M invested in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 9 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
15% less capital invested
Capital invested by funds: $78.8M → $66.8M (-$11.9M)
19% less funds holding
Funds holding: 43 → 35 (-8)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Prelude Capital Management
New York
|
+$235K |
| 2 |
FTUS
Flow Traders U.S.
New York
|
+$56.8K |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$11K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$1.67K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$765 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IG
Inherent Group
New York
|
-$4.99M |
| 2 |
Millennium Management
New York
|
-$3.61M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.41M |
| 4 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$2.99M |
| 5 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$1.99M |
EQHA.U Hedge Fund Activity: Q3 2021 in Review
35 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) for Q3 2021, worth a combined $66.8M — down 15% from $78.8M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of EQHA.U and 2 opened new positions — a net loss of 7 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Prelude Capital Management, opening a new position worth an estimated $235K. The largest seller was Inherent Group, exiting entirely with an estimated $4.99M sold.
- 35 institutional investors held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) as of Q3 2021, down from 43 in Q2 2021.
- Funds reported $66.8M of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant stock for Q3 2021, down 15% quarter-over-quarter.
- 2 funds opened new EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant positions in Q3 2021 and 9 closed out, a net change of -7 holders.
- The largest EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant buyer in Q3 2021 was Prelude Capital Management, an estimated $235K added.
- The largest EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant seller in Q3 2021 was Inherent Group, an estimated $4.99M sold.
Based on aggregated 13F filings for Q3 2021.